0000899243-21-023716.txt : 20210614 0000899243-21-023716.hdr.sgml : 20210614 20210614200451 ACCESSION NUMBER: 0000899243-21-023716 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210610 FILED AS OF DATE: 20210614 DATE AS OF CHANGE: 20210614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giordano Douglas E. CENTRAL INDEX KEY: 0001431552 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 211016323 MAIL ADDRESS: STREET 1: C/O PFIZER INC. STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 131 DARTMOUTH STREET STREET 2: SUITE 502 CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-10 0 0001805387 Cerevel Therapeutics Holdings, Inc. CERE 0001431552 Giordano Douglas E. C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141 1 0 0 0 Stock Option (Right to Buy) 13.93 2021-06-10 4 A 0 58003 0.00 A 2031-06-10 Common Stock 58003 58003 D 100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date. /s/ Mark Bodenrader, as Attorney-in-Fact 2021-06-14